10-valent pneumococcal vaccine
Showing 1 - 25 of >10,000
Pneumococcal Vaccines Trial (12-Valent Pneumococcal Conjugate Vaccine)
Not yet recruiting
- Pneumococcal Vaccines
- 12-Valent Pneumococcal Conjugate Vaccine
- (no location specified)
Jan 31, 2023
Pneumococcal Infection, Streptococcus Pneumoniae Infection, Invasive Pneumococcal Disease, Protection Against Trial in Kilifi
Active, not recruiting
- Pneumococcal Infection
- +2 more
- PCV10
- PCV13
-
Kilifi, KenyaKEMRI Wellcome Trust Research Programme
Feb 23, 2022
Meningococcal Infections Trial in Worldwide (MenACYW conjugate vaccine, Meningococcal group A, C, W-135, and Y conjugate
Active, not recruiting
- Meningococcal Infections
- MenACYW conjugate vaccine
- +5 more
-
Chlumec Nad Cidlinou, Czechia
- +30 more
Jan 4, 2023
Healthy Volunteers Trial in Shijiangzhuang (15-valent pneumococcal conjugate vaccine 202210001, 15-valent pneumococcal conjugate
Recruiting
- Healthy Volunteers
- 15-valent pneumococcal conjugate vaccine 202210001
- +4 more
-
Shijiangzhuang, Hebei, ChinaHebei Provincial Center for Disease Control and Prevention
Jul 11, 2023
Streptococcus Pneumonia, Vaccine Preventable Disease Trial (PNEUMOSIL®)
Not yet recruiting
- Streptococcus Pneumonia
- Vaccine Preventable Disease
- PNEUMOSIL®
- (no location specified)
Nov 21, 2021
Pneumococcal Infections Trial in Helsinki (10-valent pneumococcal conjugate vaccine, PCV10)
Completed
- Pneumococcal Infections
- 10-valent pneumococcal conjugate vaccine, PCV10
-
Helsinki, FinlandFinnish Institute for Health and Welfare
Aug 10, 2021
Pneumococcal Infections Trial in Yuanping, Yuncheng (Experimental 23-valent Pneumococcal)
Not yet recruiting
- Pneumococcal Infections
- Experimental 23-valent Pneumococcal
-
Yuanping, Shanxi, China
- +1 more
Feb 7, 2023
Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)
Not yet recruiting
- Pneumococcal Vaccines
- IVT PCV-25 Formulation A
- +3 more
-
Vancouver, British Columbia, Canada
- +3 more
Oct 10, 2023
Pneumococcal Vaccines Trial in Ho Chi Minh City (PCV10, PCV13)
Active, not recruiting
- Pneumococcal Vaccines
- PCV10
- PCV13
-
Ho Chi Minh City, VietnamPasteur Institute of Ho Chi Minh City
May 20, 2021
Pneumococcal Infections Trial in Kaifeng (Investigational 23-valent PPV, Control 23-valent PPV)
Completed
- Pneumococcal Infections
- Investigational 23-valent PPV
- Control 23-valent PPV
-
Kaifeng, Henan, ChinaKaifeng County Center for Disease Control and Prevention
Aug 10, 2022
Pneumococcal Disease Trial in Chengdu (23-valent pneumococcal polysaccharide vaccine, control pneumococcal polysaccharide
Recruiting
- Pneumococcal Disease
- 23-valent pneumococcal polysaccharide vaccine
- control pneumococcal polysaccharide vaccine
-
Chengdu, Sichuan, ChinaSichuan Center For Disease Control and Prevention
Sep 19, 2023
Pneumococcal Infections Trial in Weinan (Experimental 23-valent PPV, Control 23-valent PPV)
Not yet recruiting
- Pneumococcal Infections
- Experimental 23-valent PPV
- Control 23-valent PPV
-
Weinan, Shanxi, ChinaLinwei District Center for Disease Control and Prevention
Jul 26, 2022
Pneumococcal Infection Trial (V116, Placebo for PCV15 + PPSV23, PCV15)
Not yet recruiting
- Pneumococcal Infection
- V116
- +3 more
- (no location specified)
Jan 13, 2023
Learn About The Effects Of Pneumococcal Vaccine In People With
Not yet recruiting
- HIV
- +2 more
- Vaccine Administration
-
New York, New YorkPfizer
Mar 20, 2023
20-Valent Pneumococcal Conjugate Vaccine Against Vaccine-Type
Not yet recruiting
- Pneumonia
- (no location specified)
Jul 6, 2022
COVID-19, Pneumococcal Infections Trial (NVX, PCV20, Placebo)
Not yet recruiting
- COVID-19
- Pneumococcal Infections
- NVX
- +2 more
- (no location specified)
Mar 13, 2023
Infections, Streptococcal, Streptococcus Pneumoniae Vaccines Trial in Cuernavaca, Monterrey, Mexico (Synflorix (3-Dose),
Completed
- Infections, Streptococcal
- Streptococcus Pneumoniae Vaccines
- Synflorix (3-Dose)
- +4 more
-
Cuernavaca, Morelos, Mexico
- +2 more
Feb 8, 2021
Pneumococcal Vaccines Trial in United States (31 valent pneumococcal conjugate vaccine, 20 valent pneumococcal conjugate
Recruiting
- Pneumococcal Vaccines
- 31 valent pneumococcal conjugate vaccine
- 20 valent pneumococcal conjugate vaccine
-
Mobile, Alabama
- +24 more
Nov 20, 2023
Pneumonia Trial in Taizhou (23-valent pneumococcal polysaccharide vaccine, pneumococcal vaccine polyvalent)
Completed
- Pneumonia
- 23-valent pneumococcal polysaccharide vaccine
- pneumococcal vaccine polyvalent
-
Taizhou, Jiangsu, ChinaAb&b Biotechnology Co., Ltd.JS
Apr 13, 2023
Lymphoma Trial in Houston (PCV20)
Not yet recruiting
- Lymphoma
- PCV20
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2023
Influenza and Pneumonia Trial in Taizhou (Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal
Completed
- Influenza and Pneumonia
- Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
- Separate vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
-
Taizhou, Jiangsu, China
- +3 more
Jul 20, 2022
Acute Lymphoblastic Leukemia Trial in Halifax (Prevnar®13, Pneumovax® 23, Pediacel®)
Completed
- Acute Lymphoblastic Leukemia
- Prevnar®13
- +2 more
-
Halifax, Nova Scotia, CanadaIWK Health Centre
Jun 22, 2022
Pneumococcal Vaccines Among Children and Elderly Adults.
Unknown status
- Pneumococcal Vaccine Adverse Reaction
- 10 or 13-valent pneumococcal conjugate vaccine
- +2 more
-
Suwon, Gyeonggi-do, Korea, Republic ofSungkyunkwan University
Sep 9, 2020
Pneumococcal Disease Trial (20-valent pneumococcal conjugate vaccine)
Not yet recruiting
- Pneumococcal Disease
- 20-valent pneumococcal conjugate vaccine
- (no location specified)
May 16, 2023
Streptococcus Pneumoniae Infection Trial in China (13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar
Recruiting
- Streptococcus Pneumoniae Infection
- 13-valent pneumococcal conjugate vaccine (multivalent conjugate)
- Prevenar 13
-
Hechi City, Guangxi Zhuang Autonomous Region, China
- +4 more
Feb 26, 2023